Table 4 Complications of prematurity and therapeutic interventions significantly associated with survival in VLBW infants in 2013
Variable | Died/survived | Percentage mortality | P value |
|---|---|---|---|
IPPV | |||
Yes (98) | 38 /60 | 38.8 [29.7 – 48.7] | |
No (415) | 89 /329 | 21.3 [17.6 – 25.5] | <0.001 |
Nasal CPAP | |||
Yes (290) | 61/229 | 21 [16.7 – 26.1] | |
No (61) | 25 /36 | 40.9 [29.5 – 53.5] | 0.001 |
Surfactant therapy | |||
Yes (368) | 87 /281 | 23.6 [19.6 -28.2] | |
No (189) | 62/127 | 32.8 [26.5 – 36.8] | 0.021 |
PDA | |||
Yes (54) | 7 /47 | 32.8 [26.5 – 39.8] | |
No (482) | 121 /361 | 25.1 [21.4 – 29.2] | 0.047 |
NEC | |||
Yes (41) | 18 /23 | 43.9 [29.9 – 59] | |
No (495 | 111 /384 | 22.4 [19 – 26.3] | 0.002 |